Related Experiment Video
Updated: Aug 3, 2026

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
Published on: June 3, 2016
Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding
G S Hotamisligil1, R S Johnson, R J Distel
1Department of Nutrition, Harvard School of Public Health, 665 Huntington Avenue, Boston, MA 02115, USA. CA 92093, USA.
Abstract:
Fatty acid binding proteins (FABPs) are small cytoplasmic proteins that are expressed in a highly tissue-specific manner and bind to fatty acids such as oleic and retinoic acid. Mice with a null mutation in aP2, the gene encoding the adipocyte FABP, were developmentally and metabolically normal. The aP2-deficient mice developed dietary obesity but, unlike control mice, they did not develop insulin resistance or diabetes. Also unlike their obese wild-type counterparts, obese aP2-/- animals failed to express in adipose tissue tumor necrosis factor-alpha (TNF-alpha), a molecule implicated in obesity-related insulin resistance. These results indicate that aP2 is central to the pathway that links obesity to insulin resistance, possibly by linking fatty acid metabolism to expression of TNF-alpha.
Insights
Mice lacking the adipocyte fatty acid binding protein (aP2) remained healthy despite obesity, suggesting aP2 is key in linking obesity to insulin resistance and diabetes.
Area of Science:
- Biochemistry
- Metabolic Diseases
- Molecular Biology
Background:
- Fatty acid binding proteins (FABPs) are small cytoplasmic proteins binding fatty acids.
- FABPs exhibit tissue-specific expression patterns.
- Adipocyte FABP (aP2) plays a role in fatty acid metabolism.
Purpose of the Study:
- To investigate the role of aP2 in the development of obesity-related insulin resistance.
- To determine if aP2 deficiency impacts metabolic responses to a high-fat diet.
- To explore the link between aP2, fatty acid metabolism, and inflammatory markers in obesity.
Main Methods:
- Generation and characterization of mice with a null mutation in the aP2 gene (aP2-/-).
- Feeding wild-type and aP2-/- mice a high-fat diet to induce obesity.
- Assessment of metabolic parameters including insulin sensitivity and glucose tolerance.
- Measurement of adipose tissue gene expression, including tumor necrosis factor-alpha (TNF-alpha).
Main Results:
- aP2-deficient mice were developmentally and metabolically normal.
- Obese aP2-/- mice did not develop insulin resistance or diabetes, unlike obese wild-type controls.
- Obese aP2-/- mice failed to express TNF-alpha in adipose tissue, a molecule linked to insulin resistance.
Conclusions:
- aP2 is a critical mediator in the pathway connecting obesity to insulin resistance.
- aP2 may link fatty acid metabolism to the expression of TNF-alpha in adipose tissue.
- Targeting aP2 could offer a novel therapeutic strategy for preventing obesity-related metabolic dysfunction.
Related Concept Videos
Obesity
Insulin: The Receptor and Signaling Pathways

